When will Beam Therapeutics submit a BLA for Risto-cel?
2.0 puan (24s)Health & MedicineOne-OffBilim1ay
KalshiKullanılabilirliği kontrol etKYC gerekli%2 ücretDoğrulanmış sonuçlanma verisiOrta düzey kalibreGüncel ima edilen olasılık
before April 2027 93%6 seçenek arasında lider
Piyasa kalitesi
59 / 100
Orta kalite24s Hacim
₺24,3 B
Likidite
₺978,6 B
Orta likiditeSpread
3.0 pt
Orta spreadPiyasa verileri
13 dakika önce güncellendi
24 Mar 26 14:00 UTC1 Kas 26 05:00 UTC
Trendler
İlgili Piyasalar
Bağlam için ilgili sorular; eşdeğer sözleşmelerin karşılaştırması değildir.
FDA decision: Ivonescimab by Summit Therapeutics (in 2026)
KalshiFDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
KalshiWhen will Compass Pathways submit a NDA for COMP360 psilocybin?
KalshiWill we get room temperature superconductors before 2033?
Manifold MarketsWill we get room temperature superconductors before 2031?
Manifold MarketsWill we get room temperature superconductors before 2032?
Manifold MarketsKurallar
If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Sep 1, 2026, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Oct 1, 2026, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Nov 1, 2026, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Dec 1, 2026, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Jan 1, 2027, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Apr 1, 2027, then the market resolves to Yes.
Açık piyasalar
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No+0.4pt97%
- Yes-0.4pt3%
- Toplam Hacim
- ₺883,7 Mn
- 24s Hacim
- ₺3 Mn
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No98%
- Yes2%
- Toplam Hacim
- ₺92,6 Mn
- 24s Hacim
- ₺768,9 B
KALSHIPandemic in 2026?
- No96%
- Yes-1.0pt4%
- Toplam Hacim
- ₺35,3 Mn
- 24s Hacim
- ₺747,5 B
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000-1.0pt97%
- Above 600061%
+2 daha fazla sonuç
- Toplam Hacim
- ₺49,1 Mn
- 24s Hacim
- ₺145,8 B
POLYMARKETNew pandemic in 2026?
- No-1.0pt93.1%
- Yes+1.0pt6.9%
- Toplam Hacim
- ₺52,1 Mn
- 24s Hacim
- ₺99,2 B
KALSHICyclosporiasis cases reported in the US in 2026?
- Above 18k99%
- Above 6k99%
- Above 10k99%
+12 daha fazla sonuç
- Toplam Hacim
- ₺1,8 Mn
- 24s Hacim
- ₺73,4 B
- Healthcare AI adoption in September
- FDA decision: Ivonescimab by Summit Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- Measles cases in U.S. by September 30?
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve any psychedelic substance for medical use this year?
- How many human screwworm cases will be reported in the United States in 2026?
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- Which countries will have an Ebola case in 2026?
- Ebola: new country confirmed before October 1?
- Will the FDA approve MDMA for PTSD?
Sık sorulan sorular
- When will Beam Therapeutics submit a BLA for Risto-cel? için güncel oranlar nedir?
- Kalshi, 11 Eylül 2026 itibarıyla before April 2027 için 93% fiyatlıyor.
- When will Beam Therapeutics submit a BLA for Risto-cel? ne zaman sonuçlanacak?
- When will Beam Therapeutics submit a BLA for Risto-cel? için öngörülen sonuçlanma tarihi 1 Kasım 2026.
- When will Beam Therapeutics submit a BLA for Risto-cel? nasıl sonuçlandırılıyor?
- Kalshi bu piyasayı şu şekilde sonuçlandırır: If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Sep 1, 2026, then the market resolves to Yes.